Menu Login / Registration Search
CZ

CLIA CMV IgM

Chemiluminescence kit for the detection of IgM antibodies to Cytomegalovirus in human serum or plasma

Available
Catalog Number: CL-CMM100
Size: 100 tests
Regulatory status: CE IVD
Clinical topic: Infectious Diseases
Diagnostic panel: Herpes Viruses
TORCH
CLIA CMV IgM
  • Detection of IgM antibodies to Human Cytomegalovirus (CMV)
  • Detection of CMV infection
  • Disease staging
  • Intended for human serum, citrate plasma
  • Purified and inactivated antigen isolated from CMV AD 169 strain with a high content of specific immunodominant epitopes used

Human cytomegalovirus (CMV, Human Herpesvirus 5, HHV 5) is a member of the Herpetoviridae family. In humans, it is mainly transmitted by the respiratory apparatus or urogenital tract. The disease is usually asymptomatic or mild, the latent infection can be reactivated in pregnancy, serious disease, stress, or immunosuppressive treatment. An individuum can be reinfected by a different CMV strain. CMV infection during pregnancy causes developmental defects. The virus is easily transmitted through the placenta during primary infection (in 30-50 % of cases); during the reactivation stage, transplacental transmission occurs in only 1% of cases. CMV infection belongs to the TORCH syndrome.

Serological methods are used for the detection of specific IgA, IgM, and IgG (avidity) antibodies to CMV in laboratory diagnosis of the infection.

Antibodies of IgA class are a sign of an active infection – primary infection as well as reactivation. Production of IgM antibodies usually increases a few weeks after infection or reactivation and then decreases slowly. IgM determination alone cannot discriminate primary infection from reactivation. Specific IgG seroconversion indicates primary infection. The method of IgG avidity detection is used for discrimination between primary infection and reactivation. It is important for the risk assessment of congenital transmission.

Detection of IgG antibodies to CMV is also used as a standard method for screening blood donors.

Technical specifications

Technical data
Related Products
Downloads

Technical data

Assay stability30 days on board stability / In use stability until the expiration date at storage temperature 2-8 °C
Sample matrix Serum, Plasma
Measuring range0.5 - 160 U/ml
Assay/kit contentReagent Cartridge with specific reagents for the assay, magnetic particles, calibrators
Complementary productsWash buffer, Anchor® Tips, Stackable cuvettes, Trigger solutions
Note

The kits are CE-IVD certified and intended for professional use.

Related Products

Downloads

Safety information

Product brochure

Declaration of conformity

EC Certificate

Find documents for the lot

Do you want to learn more about products? We're here for you.

Please fill in
all fields
marked *
Up